A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek... Read more
A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek... Read more
Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The big players of the industry are thus looking... Read more
The global bioscience industry, in 2012, reported 450 mergers and acquisitions (M&A) transactions valued at $67 billion, which is about 10 percent lower than the... Read more
Samsung India strengthened its presence in the health and medical equipment business in the country by launching digital radiology and in-vitro diagnostics equipment... Read more
Singapore: EffRx Pharmaceuticals announced the signing of an exclusive distribution agreement with Ahn-Gook Pharmaceutical for Binosto - EffRx's innovative osteoporosis... Read more
Clocking revenues of $995.40 million, Dong-A pharmaceutical is acknowledged as a leading name in Korea's pharmaceutical industry. Over the years, the company has... Read more
Singapore: Mr David Song, president and CEO, Biocnd, signed an agreement with Dr Joe Zhou, CEO, Genor Biopharma, for the co-development of two monoclonal antibody... Read more
Singapore: Japan partially suspended imports of wheat from the US on Friday after the US government revealed that a strain of genetically engineered wheat, which... Read more
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
